dc.creatorKrettli, Antoniana Ursine
dc.date2014-02-14T17:33:01Z
dc.date2014-02-14T17:33:01Z
dc.date2009
dc.date.accessioned2023-09-26T23:36:21Z
dc.date.available2023-09-26T23:36:21Z
dc.identifierKRETTLI, Antoniana Ursine. Antimalarial drug discovery: screening of Brazilian medicinal plants and purified compound. Expert Opin. Drug Discov. , v. 4, n. 2, p. 95-108, 2009.
dc.identifier1746-044
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/7312
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8892319
dc.descriptionBackground: Malaria is the most important parasitic disease and its control depends on specific chemotherapy, now complicated by Plasmodium falciparum that has become resistant to most commonly available antimalarials. Treatment of the disease requires quinine or drug combinations of artemisinin derivatives and other antimalarials. Further drug resistance is expected. New active compounds need to be discovered. Objective/method: To find new anti-malarials from medicinal and randomly collected plants, crude extracts are screened against P. falciparum in cultures and in malaria animal moders, following bioassays of purified fractions, and cytotoxicity tests. Conclusion: For antimalarial research, screening medicinal plants is more efficient than screening randomly chosen plants. Biomonitored fractionation allows selection of new active molecules identified as potential antimalarials in multidisciplinary projects in Brazil; no new molecule is available for human testing. The advantages of projects based on ethnopharmacology are discussed.
dc.formatapplication/pdf
dc.languageeng
dc.publisherInforma Health Care
dc.rightsrestricted access
dc.subjectantimalarials
dc.subjectartemisinin derivatives
dc.subjectchloroquine resistance
dc.subjectdrug discovery
dc.subjectdrug resistance
dc.subjectmalaria, medicinal plants
dc.subjectPhmodium falcipamm
dc.subjectquinìne
dc.titleAntimalarial drug discovery: screening of Brazilian medicinal plants and purified compound
dc.typeArticle


Este ítem pertenece a la siguiente institución